Abstract
The usefulness of histopathological grading in predicting the prognosis of patients with ependymomas is controversial. To clarify the discrepancy between the histological malignancy and the prognosis of these tumors, we estimated the proliferative potential of 32 intracranial and intraspinal ependymomas and correlated the findings with the clinical behavior. Each patient received an intraoperative infusion of bromodeoxyuridine (BUdR, 200 mg/m2 i.v.) before tumor removal; the BUdR labeling index (LI), or percentage of BUdR-labeled cells, was determined immunohistochemically in excised specimens. The mean BUdR LI (±SD) of intracranial malignant ependymomas was 4.1±2.8%. Nonmalignant intracranial and intraspinal ependymomas and subependymomas had mean LIs of 1.5±0.9%, 1.1±0.3%, and <1%, respectively. Overall, 44% of the tumors recurred. There were no statistically significant differences in the recurrence rates of intracranial and intraspinal ependymomas, including subependymomas (43% and 44%, respectively), or of intracranial ependymomas with LIs greater than 1.0% and less than 1.0% (67% and 44%, respectively). However, the early recurrence rate (within 24 months after treatment) of tumors with LIs greater than 1.0% was higher than that of tumors with LIs of less than 1.0% (100% vs. 25%, P<0.05). The BUdR LI also showed a statistically significant inverse correlation with the time to recurrence. These findings indicate that BUdR LI reflects the proliferative potential of individual ependymomas and can be used to help predict the recurrence and estimate the prognosis of these tumors.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Afra D, Muller W, Slowik F, Wilcke O, Budka H, Turoczy L (1983) Supratentorial lobar ependymomas: reports on the grading and survival periods in 80 cases, including 46 recurrences. Acta Neurochir (Wien) 69:243–251
Barone BM, Elvidge AR (1970) Ependymomas: a clinical survey. J Neurosurg 33:428–438
Cooper PR, Epstein F (1985) Radical resection of intramedullary spinal cord tumors in adults. Recent experience in 29 patients. J Neurosurg 63:492–499
Di Marco A, Griso C, Pradella R, Campostrini F, Garusi GF (1988) Postoperative management of primary spinal cord ependymomas. Acta Oncol 27:371–375
Dohrmann GJ, Farwell JR, Flannery JT (1976) Ependymomas and ependymoblastomas in children. J Neurosurg 45:273–283
Enzmann DR, Norman D, Levin V, Wilson CB, Newton TH (1978) Computed tomography in the follow-up of medulloblastomas and ependymomas. Radiology 128:57–63
Fischer G, Mansuy L (1980) Total removal of intramedullary ependymomas: follow-up study of 16 cases. Surg Neurol 14:243–249
Garrett PG, Simpson WJK (1983) Ependymomas: results of radiation treatment. Int J Radiat Oncol Biol Phys 9:1121–1124
Hoshino T, Prados M, Wilson CB, Cho KG, Lee K-S, Davis RL (1989) Prognostic implications of bromodeoxyuridine labeling index of human gliomas. J Neurosurg 71:335–341
Kim YH, Fayos JV (1977) Intracranial ependymomas. Radiology 124:805–808
Kopelson G, Linggood RM, Kleinman GM, Doucette J, Wang CC (1980) Management of intramedullary spinal cord tumors. Radiology 135:473–479
Kricheff II, Becker M, Schneck SA, Taveras JM (1964) Intracranial ependymomas: factors influencing prognosis. J Neurosurg 21:7–14
Marks JE, Adler SJ (1982) A comparative study of ependymomas by site of origin. Int J Radiat Oncol Biol Phys 8:37–43
Matsumura A, Ahyai A, Hori A, Schaake T (1989) Intracerebral subependymomas. Clinical and neuropathological analysis with special reference to the possible existence of a less benign variant. Acta Neurochir (Wien) 96:15–25
Mork SJ, Loken AC (1977) Ependymoma. A follow-up study of 101 cases. Cancer 40:907–915
Nagashima T, DeArmond SJ, Murovic J, Hoshino T (1985) Immunocytochemical demonstration of S-phase cells by antibromodeoxyuridine monoclonal antibody in human brain tumor tissues. Acta Neuropathol (Berl) 67:155–159
Nagashima T, Hoshino T, Cho KG, Edwards MSB, Hudgins RJ, Davis RL (1988) The proliferative potential of human ependymomas measured by in situ bromodeoxyuridine labeling. Cancer 61:2433–2438
Nazar GB, Hoffman HJ, Becker LE, Jenkin D, Humphreys RP, Hendrick EB (1990) Infratentorial ependymomas in childhood: prognostic factors and treatment. J Neurosurg 72:408–417
Phillips TL, Sheline GE, Boldrey E (1964) Therapeutic considerations in tumors affecting the central nervous system: ependymomas. Am J Roentgenol 83:98–105
Rorke LB, Gilles FH, Davis RL, Becker LE (1985) Revision of the World Health Organization classification of brain tumors for childhood brain tumors. Cancer 56:1869–1886
Ross GW, Rubinstein LJ (1989) Lack of histopathological correlation of malignant ependymomas with postoperative survival. J Neurosurg 70:31–36
Russell DS, Rubinstein IJ (1977) Pathology of tumours of the nervous system, 4th edn. Arnold, London, pp 212–213
Salazar OM, Castro-Vita H, VanHoutte P, Rubin P, Aygun C (1983) Improved survival in cases of intracranial ependymoma after radiation therapy. Late report and recommendations. J Neurosurg 59:652–659
Shuman RM, Alvord EC, Leech RW (1975) The biology of childhood ependymomas. Arch Neurol 32:731–739
Wallner KE, Wara WM, Sheline GE, Davis RL (1986) Intracranial ependymomas: results of treatment with partial or whole brain irradiation without spinal irradiation. Int J Radiat Oncol Biol Phys 12:1937–1941
Reference
Schiffer D, Chio A, Cravioto H, Giordana MT, Migheli A, Palma L, Pollo B, Soffietti R, Tribolo A (1991) Ependymoma: internal correlations among pathological signs. The anaplastic variant. Neurosurgery 29:206–210
Schiffer D, Chio A, Giordana MT, Migheli A, Palma L, Pollo B, Soffietti R, Tribolo A (1991) Histologic prognostic factors in ependymoma. Child's Nerv Syst 7:177–182
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Asai, A., Hoshino, T., Edwards, M.S.B. et al. Predicting the recurrence of ependymomas from the bromodeoxyuridine labeling index. Child's Nerv Syst 8, 273–278 (1992). https://doi.org/10.1007/BF00300795
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00300795